Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition
Despite the initial effectiveness of the tyrosine kinase inhibitor lapatinib against HER2 gene-amplified breast cancers, most patients eventually relapse after treatment, implying that tumors acquire mechanisms of drug resistance. To discover these mechanisms, we generated six lapatinib-resistant HE...
Main Authors: | Rexer, Brent N., Ham, Amy-Joan L., Rinehart, Cammie, Hill, Salisha, Granja-Ingram, Nara de Matos, González, Ana María, Mills, Gordon B., Dave, Bhuvanesh, Chang, Jenny C., Liebler, Daniel C., Arteaga, Carlos L. |
---|---|
Format: | Online |
Language: | English |
Published: |
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204390/ |
Similar Items
-
Protein kinases associated with the yeast phosphoproteome
by: Brinkworth, Ross I, et al.
Published: (2006) -
Quantitative Phosphoproteomics Reveals SLP-76 Dependent Regulation of PAG and Src Family Kinases in T Cells
by: Cao, Lulu, et al.
Published: (2012) -
Regulation of the Src Family Kinases by Csk
by: Okada, Masato
Published: (2012) -
Regulation of the Src Family Kinases by Csk
by: Masato Okada
Published: (2012-01-01) -
Direct inhibition of PI3K in combination with dual HER2 inhibitors is required for optimal antitumor activity in HER2+ breast cancer cells
by: Rexer, Brent N, et al.
Published: (2014)